KEVIN P STARR Insider Trading $MYOK MyoKardia, Inc.
Get free email notifications about insider trading for KEVIN P STARR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KEVIN P STARR. KEVIN P STARR is Director in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and Director in ZAFGEN, INC. ($ZFGN) and 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and Director in MyoKardia Inc ($MYOK) and 10% Owner in Blueprint Medicines Corp ($BPMC) and in Sage Therapeutics, Inc. ($SAGE) and Director in Sage Therapeutics, Inc. ($SAGE) and 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and Director in Global Blood Therapeutics, Inc. ($GBT) and 10% Owner in Editas Medicine, Inc. ($EDIT).
KEVIN P STARR in MyoKardia, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KEVIN P STARR: Director
Holdings: 885,104 shares
Current Value: $10,621,248
Latest Transaction: Mar 07 2018
$MYOK Market Capitalization: $375.56M
$MYOK Previous Close: $12.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KEVIN P STARR in MyoKardia, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALNY, BPMC, CTMX, EDIT, GBT, LRMR, MYOK, SAGE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 07 2018 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | J | 0.00 | 2,000,000 | 0 | 885,104 | 2.9 M to 885.1 K (-69.32 %) |
| Jan 05 2018 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | S | 42.00 | 816,326 | 34,285,774 | 680,272 | 1.5 M to 680.3 K (-54.55 %) |
| Dec 08 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | J | 0.00 | 2,000,000 | 0 | 2,885,104 | 4.9 M to 2.9 M (-40.94 %) |
| Oct 04 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | S | 40.28 | 75,313 | 3,033,578 | 70,763 | 146.1 K to 70.8 K (-51.56 %) |
| Sep 29 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | J | 0.00 | 2,000,000 | 0 | 4,885,104 | 6.9 M to 4.9 M (-29.05 %) |
| Sep 27 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | S | 43.00 | 400,000 | 17,200,000 | 6,885,104 | 7.3 M to 6.9 M (-5.49 %) |
| Sep 27 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | S | 43.00 | 201,400 | 8,660,200 | 7,285,104 | 7.5 M to 7.3 M (-2.69 %) |
| Sep 12 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | S | 42.39 | 900 | 38,149 | 7,486,504 | 7.5 M to 7.5 M (-0.01 %) |
| Sep 12 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | S | 41.00 | 200,350 | 8,214,350 | 7,487,404 | 7.7 M to 7.5 M (-2.61 %) |
| Jun 16 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Option Exercise | A | 14.00 | 11,000 | 154,000 | 11,000 | |
| Apr 03 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | J | 0.00 | 850,000 | 0 | 7,687,754 | 8.5 M to 7.7 M (-9.96 %) |
| Dec 01 2016 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | J | 0.00 | 850,000 | 0 | 8,537,754 | 9.4 M to 8.5 M (-9.05 %) |
| Jun 09 2016 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Option Exercise | A | 13.60 | 11,000 | 149,600 | 11,000 | |
| Nov 05 2015 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Option Exercise | C | 0.00 | 5,500,000 | 0 | 0 | |
| Nov 05 2015 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Option Exercise | C | 0.00 | 32,500,000 | 0 | 0 | |
| Nov 05 2015 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Buy | C | 0.00 | 1,496,598 | 0 | 1,496,598 | 0 to 1.5 M |
| Nov 05 2015 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Buy | C | 0.00 | 8,843,537 | 0 | 9,387,754 | 544.2 K to 9.4 M (+1,625.00 %) |
Page: 1